Sustained delivery of anti-VEGF from injectable hydrogel systems provides a prolonged decrease of endothelial cell proliferation and angiogenesis in vitro
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sustained delivery of anti-VEGF from injectable hydrogel systems provides a prolonged decrease of endothelial cell proliferation and angiogenesis in vitro
Authors
Keywords
-
Journal
RSC Advances
Volume 8, Issue 16, Pages 8999-9005
Publisher
Royal Society of Chemistry (RSC)
Online
2018-02-28
DOI
10.1039/c7ra13014g
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Controlled delivery of antibodies from injectable hydrogels
- (2016) Nathan A. Fletcher et al. Materials Science & Engineering C-Materials for Biological Applications
- Repositioning Bevacizumab: A Promising Therapeutic Strategy for Cartilage Regeneration
- (2016) Soojung Lee et al. TISSUE ENGINEERING PART B-REVIEWS
- Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: preliminary in vitro studies
- (2015) Luigi Battaglia et al. NANOTECHNOLOGY
- Strategies to improve delivery of anticancer drugs across the blood–brain barrier to treat glioblastoma
- (2015) Rajneet K. Oberoi et al. NEURO-ONCOLOGY
- Controlled release of therapeutic antibody formats
- (2014) Daniel Schweizer et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The therapeutic monoclonal antibody market
- (2014) Dawn M Ecker et al. mAbs
- Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
- (2014) Samir Mitragotri et al. NATURE REVIEWS DRUG DISCOVERY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sustained release of avastin® from polysaccharides cross-linked hydrogels for ocular drug delivery
- (2013) Xu Xu et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Protein–Polyanion Interactions for the Controlled Release of Monoclonal Antibodies
- (2012) Daniel Schweizer et al. BIOMACROMOLECULES
- Anti-angiogenic gene therapy in the treatment of malignant gliomas
- (2012) NaTosha N. Gatson et al. NEUROSCIENCE LETTERS
- Effective electrophoretic mobilities and charges of anti-VEGF proteins determined by capillary zone electrophoresis
- (2011) S. Kevin Li et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Assessment of Net Charge and Protein–Protein Interactions of Different Monoclonal Antibodies
- (2011) Christian Lehermayr et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Intra-Arterial Delivery of Bevacizumab after Blood-Brain Barrier Disruption for the Treatment of Recurrent Glioblastoma: Progression-Free Survival and Overall Survival
- (2011) Jan-Karl Burkhardt et al. World Neurosurgery
- An injectable drug delivery platform for sustained combination therapy
- (2009) M. Douglas Baumann et al. JOURNAL OF CONTROLLED RELEASE
- PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION
- (2009) MAJID ABRISHAMI et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started